Publicaciones en colaboración con investigadores/as de Emory University School of Medicine (2)

2021

  1. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial

    Leukemia, Vol. 35, Núm. 9, pp. 2539-2551

2011

  1. Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

    Blood, Vol. 117, Núm. 12, pp. 3294-3301